William T Kuo, MD
Interventional Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kuo’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A91133 · Current
Licensed to practise in California · since 2005 · expires 2027-05-31 · Bowman Gray School of Medicine of Wake Forest University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,580
Medicare paid this office $28,580 for 133 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of vena cava filter with review by radiologist | 11 | $3,260 | $296 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 15 | $1,763 | $118 |
| Review by radiologist of ct guidance for needle placement | 23 | $1,448 | $60 |
| Needle biopsy of liver through skin | 19 | $1,426 | $75 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 82 | $903 | $10 |
See all 6 services
| Removal of vena cava filter with review by radiologist | 11 | $3,260 | $296 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 15 | $1,763 | $118 |
| Review by radiologist of ct guidance for needle placement | 23 | $1,448 | $60 |
| Needle biopsy of liver through skin | 19 | $1,426 | $75 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 82 | $903 | $10 |
| Ultrasonic guidance for needle placement | 22 | $586 | $27 |
Who their Medicare patients are
133 Original Medicare patients in 2024. Average age 71 · Under 65 11% · 85 and older 8% · Women 44% · Also on Medicaid 27% · Health risk score 2.61. Above the middle of the specialty; the typical interventional radiology clinician is at 2.27.
Conditions among them: High blood pressure 74% · Chronic kidney disease 39% · Cancer 39% · Coronary heart disease 32% · Diabetes 31% · Atrial fibrillation 31% · Depression 26% · Heart failure 22% · COPD 17% · Dementia 11% · Stroke 11%.
The office billed $996,289, Medicare allowed $36,201 and paid $28,580; for 382 services of 73 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 133 | 382 | 71 | 2.61 | $996,289 | $28,580 |
| 2023 | 167 | 499 | 70 | 2.85 | $1,130,857 | $41,289 |
| 2022 | 147 | 460 | 69 | 2.49 | $921,789 | $39,809 |
| 2021 | 160 | 512 | 70 | 2.32 | $998,928 | $45,168 |
| 2020 | 150 | 435 | 68 | 2.64 | $806,719 | $41,253 |
| 2019 | 191 | 581 | 69 | 3.05 | $1,041,881 | $53,285 |
| 2018 | 192 | 668 | 69 | 2.75 | $1,123,181 | $63,777 |
| 2017 | 159 | 485 | 68 | 2.31 | $1,117,011 | $53,971 |
| 2016 | 145 | 399 | 68 | 2.38 | $1,122,057 | $51,418 |
| 2015 | 146 | 469 | 70 | 2.76 | $1,054,620 | $50,592 |
| 2014 | 157 | 426 | 67 | 2.64 | $803,443 | $44,847 |
| 2013 | 190 | 585 | 69 | 2.62 | $1,004,227 | $57,358 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of vena cava filter with review by radiologist | 24 | $6,837 | $285 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 13 | $1,771 | $136 |
| Needle biopsy of liver through skin | 17 | $1,366 | $80 |
| Review by radiologist of ct guidance for needle placement | 20 | $1,286 | $64 |
| Needle biopsy of growth of abdominal cavity | 12 | $893 | $74 |
| Ultrasonic guidance for needle placement | 23 | $610 | $27 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 91 | $479 | $5 |
| Ultrasonic guidance for blood vessel access | 15 | $237 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $187 | $11 |
2022: 7 services
| Removal of vena cava filter with review by radiologist | 29 | $7,969 | $275 |
| Balloon dilation of vein with review by radiologist, initial vein | 11 | $1,955 | $178 |
| Needle biopsy of liver through skin | 15 | $1,209 | $81 |
| Review by radiologist of ct guidance for needle placement | 17 | $1,104 | $65 |
| Ultrasonic guidance for needle placement | 19 | $532 | $28 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 99 | $503 | $5 |
| Ultrasonic guidance for blood vessel access | 17 | $236 | $12 |
2021: 11 services
| Removal of vena cava filter with review by radiologist | 36 | $10,463 | $291 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 16 | $2,246 | $140 |
| Balloon dilation of vein with review by radiologist, initial vein | 15 | $2,119 | $141 |
| Review by radiologist of ct guidance for needle placement | 27 | $1,797 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 96 | $1,124 | $11 |
| Needle biopsy of liver through skin | 11 | $978 | $82 |
| Insertion of tube into vein, second order branch | 12 | $918 | $76 |
| Needle biopsy or removal of surface lymph nodes | 14 | $899 | $60 |
| Ultrasonic guidance for needle placement | 23 | $629 | $27 |
| Ultrasonic guidance for blood vessel access | 15 | $227 | $13 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $112 | $5 |
2020: 6 services
| Removal of vena cava filter with review by radiologist | 29 | $8,896 | $307 |
| Drainage of fluid collection of abdominal cavity by tube using imaging guidance | 11 | $2,036 | $185 |
| Replacement of kidney drainage tube using imaging guidance with review by radiologist | 13 | $1,527 | $109 |
| Review by radiologist of ct guidance for needle placement | 21 | $1,445 | $69 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 107 | $1,270 | $11 |
| Ultrasonic guidance for blood vessel access | 14 | $200 | $13 |
2019: 10 services
| Removal of vena cava filter with review by radiologist | 36 | $10,286 | $286 |
| Balloon dilation of vein with review by radiologist, initial vein | 20 | $3,462 | $157 |
| Insertion of stomach tube using fluoroscopic guidance with contrast | 12 | $2,192 | $183 |
| Review by radiologist of ct guidance for needle placement | 32 | $2,156 | $67 |
| Drainage of fluid collection of abdominal cavity by tube using imaging guidance | 13 | $2,153 | $144 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 139 | $1,564 | $11 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 15 | $1,178 | $79 |
| Needle biopsy of liver through skin | 12 | $874 | $73 |
| Ultrasonic guidance for needle placement | 11 | $293 | $27 |
| Ultrasonic guidance for blood vessel access | 12 | $208 | $13 |
2018: 10 services
| Removal of vena cava filter with review by radiologist | 44 | $12,512 | $284 |
| Balloon dilation of vein with review by radiologist, initial vein | 22 | $3,014 | $137 |
| New patient visit (45+ min) | 27 | $2,882 | $107 |
| Insertion of stomach tube using fluoroscopic guidance with contrast | 11 | $2,075 | $189 |
| Replacement of liver duct drainage tube using imaging guidance with review by radiologist | 14 | $1,758 | $103 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 141 | $1,651 | $11 |
| Review by radiologist of ct guidance for needle placement | 26 | $1,339 | $52 |
| Needle biopsy of liver through skin | 11 | $823 | $75 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 11 | $790 | $72 |
| Ultrasonic guidance for blood vessel access | 27 | $398 | $13 |
2017: 8 services
| Removal of vena cava filter with review by radiologist | 46 | $12,912 | $281 |
| Removal and dissolving of blood clot from vein using fluoroscopic guidance, initial treatment | 14 | $4,656 | $333 |
| Balloon dilation of vein with review by radiologist, initial vein | 23 | $3,434 | $149 |
| New patient visit (45+ min) | 28 | $3,003 | $107 |
| Review by radiologist of ct guidance for needle placement | 34 | $1,801 | $51 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 18 | $1,467 | $82 |
| Insertion of tube into vein, first order branch | 15 | $1,137 | $76 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $666 | $11 |
2016: 6 services
| Removal of vena cava filter with review by radiologist | 59 | $17,747 | $301 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 35 | $4,476 | $128 |
| New patient visit (45+ min) | 21 | $2,307 | $110 |
| Review by radiologist of ct guidance for needle placement | 23 | $1,190 | $52 |
| New patient visit (30+ min) | 15 | $1,017 | $68 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 35 | $814 | $23 |
2015: 9 services
| Removal of vena cava filter with review by radiologist | 34 | $11,005 | $324 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 19 | $3,509 | $130 |
| Review by radiologist of ct guidance for needle placement | 24 | $1,241 | $52 |
| Ultrasound evaluation of blood vessel during diagnosis or treatment | 11 | $1,186 | $91 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 11 | $953 | $87 |
| New patient visit (30+ min) | 13 | $882 | $68 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 19 | $641 | $23 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 13 | $599 | $32 |
| Radiological supervision and interpretation of ultrasound of blood vessel | 11 | $222 | $17 |
2014: 7 services
| Removal of vena cava filter with review by radiologist | 26 | $8,313 | $320 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 13 | $3,047 | $160 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 22 | $2,086 | $95 |
| Review by radiologist of ct guidance for needle placement | 38 | $1,948 | $51 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 13 | $488 | $23 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 13 | $456 | $30 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $185 | $17 |
2013: 12 services
| Removal of vena cava filter with review by radiologist | 29 | $8,696 | $300 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 11 | $2,619 | $238 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 15 | $2,076 | $122 |
| Review by radiologist of ct guidance for needle placement | 35 | $1,701 | $47 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 22 | $1,660 | $75 |
| Drainage of abscess behind abdominal cavity | 11 | $1,620 | $135 |
| New patient visit (45+ min) | 12 | $1,353 | $113 |
| Review by radiologist of image for drainage of fluid | 18 | $1,004 | $50 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 20 | $850 | $30 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 15 | $406 | $23 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 20 | $321 | $16 |
| Review by radiologist of abscess or sinus cavity study | 11 | $274 | $21 |
Medicaid work
$1,335 in 2024
Medicaid paid $1,335 for 25 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| IP/OBS CONSLTJ NEW/EST SF 35 | 25 | $1,335 |
| 2024 | 25 | 1 | 24 | $1,335 |
| 2019 | 13 | 1 | 13 | $288 |
| 2018 | 14 | 1 | 12 | $196 |
See the largest Medicaid services in earlier years
2019
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $288 |
2018
| Injection, midazolam hydrochloride, per 1 mg | 14 | $196 |
Money from drug and device companies
$135 in 2025
| 2025 | 3 | 3 | None | $135 |
| 2024 | 4 | 8 | None | $545 |
| 2023 | 1 | 1 | None | $30 |
| 2022 | 1 | 1 | None | $42 |
| 2019 | 1 | 2 | None | $70 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bard Peripheral Vascular | Venovo | $72 | 1 payment
|
| Boston Scientific | Lithovue | $34 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $30 | 1 payment
|
See all 3 published payments
| Boston Scientific | Meals · 2025-12-01 | Lithovue | $34 |
| Bard Peripheral Vascular | Meals · 2025-04-09 | Venovo | $72 |
| Sanofi Pasteur | Meals · 2025-02-11 | Fluzone High-Dose | $30 |
See earlier years (2024, 2023, 2022, 2019)
2024: $545
| Axonics | Axonics | $298 | 4 payments
|
| Bard Peripheral Vascular | Venovo | $150 | 1 payment
|
| Abiomed | Impella | $60 | 1 payment
|
| Abbott Laboratories | Esprit | $37 | 2 payments
|
2023: $30
| Abbott Laboratories | Jeti | $30 | 1 payment
|
2022: $42
| Philips Electronics North America | (1661) Clin Edu Igt | $42 | 1 payment
|
2019: $70
| Bard Peripheral Vascular | Venovo | $70 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Vesper Medical · Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the Duo Venous Stent System (Vivid) · 2023 | Their institution | $35,117 |
| Vesper Medical · Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the Duo Venous Stent System (Vivid) · 2022 | Their institution | $21,228 |
| Abbott Laboratories · Jet Enhanced Thrombectomy Intervention Registry - Jeti Registry · 2024 | Their institution | $19,269 |
| Abbott Laboratories · Jeti Peripheral Thrombectomy Registry (Jeti) · 2023 | Their institution | $13,598 |
| Philips North America LLC · Other Study Related Fees and Subject Costs · 2025 | Their institution | $10,187 |
| Abbott Laboratories · Nct04370691--Jeti Lower Extremity Arterial Thrombosis · 2025 | Their institution | $8,734 |
| Abbott Laboratories · Jet Enhanced Thrombectomy Intervention Registry · 2024 | Their institution | $2,867 |
| Philips North America LLC · Vivid · 2024 | Their institution | $2,771 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023128428
- Licence
- CA A91133California A91133: Current · expires 2027-05-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-08-30
- NPI last updated
- 2024-04-08
- NPI record certified
- 2024-04-08
This is when the NPI record was last certified, not a medical board exam.